FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2884289604> ?p ?o ?g. }

• W2884289604 endingPage "14" @default.
• W2884289604 startingPage "1" @default.
• W2884289604 abstract "MDM2 amplification can promote tumorigenesis directly or indirectly through p53 inhibition. MDM2 has increasing clinical relevance because inhibitors are under evaluation in clinical trials, and MDM2 amplification is a possible genomic correlate of accelerated progression, known as hyperprogression, after anti-PD-1/PD-L1 immunotherapy. We used next-generation sequencing (NGS) to ascertain MDM2 amplification status across a large number of diverse cancers.We interrogated the molecular profiles of 102,878 patients with diverse malignancies for MDM2 amplification and co-altered genes using clinical-grade NGS (182 to 465 genes).MDM2 amplification occurred in 3.5% of patients (3,650 of 102,878). The majority of tumor types had a small subset of patients with MDM2 amplification. Most of these patients (99.0% [3,613/3,650]) had co-alterations that accompanied MDM2 amplification. Various pathways, including those related to tyrosine kinase (37.9% [1,385 of 3,650]), PI3K signaling (25.4% [926 of 3,650]), TP53 (24.9% [910 of 3,650]), and MAPK signaling (23.6% [863 of 3,650]), were involved. Although infrequent, mismatch repair genes and PD-L1 amplification also were co-altered (2.2% [79 of 3,650]). Most patients (97.6% [3,563 of 3,650]) had one or more co-alterations potentially targetable with either a Food and Drug Administration-approved or investigational agent. MDM2 amplifications were less frequently associated with high tumor mutation burden compared with the MDM2 wild-type population (2.9% v 6.5%; P < .001). An illustrative patient who harbored MDM2 amplification and experienced hyperprogression with an immune checkpoint inhibitor is presented.MDM2 amplification was found in 3.5% of 102,878 patients, 97.6% of whom harbored genomic co-alterations that were potentially targetable. This study suggests that a small subset of most tumor types have MDM2 amplification as well as pharmacologically tractable co-alterations." @default.
• W2884289604 created "2018-08-03" @default.
• W2884289604 creator A5005582681 @default.
• W2884289604 creator A5022820783 @default.
• W2884289604 creator A5035961942 @default.
• W2884289604 creator A5043675371 @default.
• W2884289604 creator A5053481267 @default.
• W2884289604 creator A5086626483 @default.
• W2884289604 creator A5088559019 @default.
• W2884289604 date "2018-11-01" @default.
• W2884289604 modified "2023-10-18" @default.
• W2884289604 title "Analysis of <i>MDM2</i> Amplification: Next-Generation Sequencing of Patients With Diverse Malignancies" @default.
• W2884289604 cites W1153405174 @default.
• W2884289604 cites W1813521438 @default.
• W2884289604 cites W1867768655 @default.
• W2884289604 cites W1940241680 @default.
• W2884289604 cites W1976295398 @default.
• W2884289604 cites W1995868292 @default.
• W2884289604 cites W2023486531 @default.
• W2884289604 cites W2025183726 @default.
• W2884289604 cites W2056955003 @default.
• W2884289604 cites W2099791897 @default.
• W2884289604 cites W2103724490 @default.
• W2884289604 cites W2106048601 @default.
• W2884289604 cites W2115775023 @default.
• W2884289604 cites W2117752226 @default.
• W2884289604 cites W2118129019 @default.
• W2884289604 cites W2125616358 @default.
• W2884289604 cites W2130940380 @default.
• W2884289604 cites W2136859769 @default.
• W2884289604 cites W2154171668 @default.
• W2884289604 cites W2159322582 @default.
• W2884289604 cites W2160981405 @default.
• W2884289604 cites W2161375781 @default.
• W2884289604 cites W2168062283 @default.
• W2884289604 cites W2192184960 @default.
• W2884289604 cites W2200963198 @default.
• W2884289604 cites W2294723338 @default.
• W2884289604 cites W2412140884 @default.
• W2884289604 cites W2460318004 @default.
• W2884289604 cites W2473498748 @default.
• W2884289604 cites W2504980652 @default.
• W2884289604 cites W2518057821 @default.
• W2884289604 cites W2539418106 @default.
• W2884289604 cites W2554618897 @default.
• W2884289604 cites W2596468903 @default.
• W2884289604 cites W2600173499 @default.
• W2884289604 cites W2601621622 @default.
• W2884289604 cites W2605497049 @default.
• W2884289604 cites W2606495925 @default.
• W2884289604 cites W2627067328 @default.
• W2884289604 cites W2747774814 @default.
• W2884289604 cites W2761936165 @default.
• W2884289604 cites W2776946053 @default.
• W2884289604 cites W2797465271 @default.
• W2884289604 cites W3217485783 @default.
• W2884289604 cites W4294718043 @default.
• W2884289604 doi "https://doi.org/10.1200/po.17.00235" @default.
• W2884289604 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6106866" @default.
• W2884289604 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30148248" @default.
• W2884289604 hasPublicationYear "2018" @default.
• W2884289604 type Work @default.
• W2884289604 sameAs 2884289604 @default.
• W2884289604 citedByCount "36" @default.
• W2884289604 countsByYear W28842896042018 @default.
• W2884289604 countsByYear W28842896042019 @default.
• W2884289604 countsByYear W28842896042020 @default.
• W2884289604 countsByYear W28842896042021 @default.
• W2884289604 countsByYear W28842896042022 @default.
• W2884289604 countsByYear W28842896042023 @default.
• W2884289604 crossrefType "journal-article" @default.
• W2884289604 hasAuthorship W2884289604A5005582681 @default.
• W2884289604 hasAuthorship W2884289604A5022820783 @default.
• W2884289604 hasAuthorship W2884289604A5035961942 @default.
• W2884289604 hasAuthorship W2884289604A5043675371 @default.
• W2884289604 hasAuthorship W2884289604A5053481267 @default.
• W2884289604 hasAuthorship W2884289604A5086626483 @default.
• W2884289604 hasAuthorship W2884289604A5088559019 @default.
• W2884289604 hasBestOaLocation W28842896041 @default.
• W2884289604 hasConcept C104317684 @default.
• W2884289604 hasConcept C121608353 @default.
• W2884289604 hasConcept C143998085 @default.
• W2884289604 hasConcept C2776192174 @default.
• W2884289604 hasConcept C2908647359 @default.
• W2884289604 hasConcept C502942594 @default.
• W2884289604 hasConcept C54355233 @default.
• W2884289604 hasConcept C555283112 @default.
• W2884289604 hasConcept C71924100 @default.
• W2884289604 hasConcept C7602840 @default.
• W2884289604 hasConcept C86803240 @default.
• W2884289604 hasConcept C99454951 @default.
• W2884289604 hasConceptScore W2884289604C104317684 @default.
• W2884289604 hasConceptScore W2884289604C121608353 @default.
• W2884289604 hasConceptScore W2884289604C143998085 @default.
• W2884289604 hasConceptScore W2884289604C2776192174 @default.
• W2884289604 hasConceptScore W2884289604C2908647359 @default.
• W2884289604 hasConceptScore W2884289604C502942594 @default.
• W2884289604 hasConceptScore W2884289604C54355233 @default.

• next